Merit Financial Group, LLC Annovis Bio, Inc. Transaction History
Merit Financial Group, LLC
- $8.37 Billion
- Q2 2025
A detailed history of Merit Financial Group, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 91,316 shares of ANVS stock, worth $252,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,316
Previous 97,816
6.65%
Holding current value
$252,945
Previous $161,000
22.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANVS
# of Institutions
50Shares Held
1.82MCall Options Held
102KPut Options Held
98.3K-
Vanguard Group Inc Valley Forge, PA697KShares$1.93 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$507,7040.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA165KShares$455,8250.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$278,9630.0% of portfolio
-
Marshall Wace, LLP London, X090.9KShares$251,8120.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $22.6M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...